Thomas A. Luger

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

Laure Gossec, Josef S Smolen, Sofía Ramiro et al. · Annals of the Rheumatic Diseases · 2016 · 913 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

Kenneth B. Gordon, Andrew Blauvelt, Kim Papp et al. · New England Journal of Medicine · 2016 · 838 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

A Köck, Thomas Schwarz, Reinhard Kirnbauer et al. · The Journal of Experimental Medicine · 1990 · 709 citations · Full text

Medicine, Dermatology, Immunology +13

Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

Johannes Ring, A. Alomar, Thomas Bieber et al. · Journal of the European Academy of Dermatology and Venereology · 2012 · 682 citations

Life Sciences, Dermatology, Immunology +10

Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin

Martin Steinhoff, Ulrich Neisius, Akihiko Ikoma et al. · Journal of Neuroscience · 2003 · 642 citations · Full text

Medicine, Dermatology, Pharmacology +17